Coherus Biosciences | CHRS - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 384.69B 19.14B 2026-03
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 8.17B 562M 2026-07
Alnylam Pharmaceuticals USD 26.51B 13.68B 2026-07
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 13.65B 2.64B 2026-07
Biogen USD 30.52B 1.38B 2026-07
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 131.55B 13.89B 2026-07
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Fujifilm JPY 3.69T 340.04B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Merck USD 297.1B 35.84B 2026-03
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.78B 146M 2026-07
Regeneron Pharmaceuticals USD 81.04B 15.67B 2026-07
Sarepta Therapeutics USD 2.28B 30M 2026-03
Teva Pharmaceutical Industries USD 118.38B 3.84B 2026-07
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Xencor USD 893M 200M 2026-03
Zoetis USD 49.71B 5.74B 2026-03